Iterum Therapeutics plc (ITRM )

Currency in USD Disclaimer
$1.39 +$0.28 (25.23%)
Open 04/24/2025
$1.12
$1.42
$0.81
$3.02

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol ITRM
  • Company Iterum Therapeutics plc
  • Price $1.39
  • Changes Percentage 25.23
  • Change 0.28
  • Day Low $1.12
  • Day High $1.42
  • Year High $3.02
  • Year Low $0.81
  • Market Cap $48,068,146
  • Price Avg 50 EMA (D) $1.31
  • Price Avg 200 EMA (D) $1.39
  • Exchange NASDAQ
  • Volume 1,449,366
  • Average Volume 424,622
  • Open $1.12
  • Previous Close $1.11
  • EPS -1.26
  • PE -1.10
  • Earnings Announcement 2025-05-12 12:30:00
  • Shares Outstanding $34,581,400

Company brief: ITERUM THERAPEUTICS PLC (ITRM )

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

ITRM Corporation News

Income Statement